Literature DB >> 19178287

Oligosaccharide promotes bioavailability of a water-soluble flavonoid glycoside, alpha G-rutin, in rats.

Noriko Matsukawa1, Megumi Matsumoto, Hideyuki Chiji, Hiroshi Hara.   

Abstract

This study examined the effects of a nondigestible saccharide, difructose anhydride (DFA) III, and fructooligosaccharides (FOS) on the intestinal absorption and metabolism of alpha G-rutin, a quercetin glycoside in rats during a 2 week feeding period with diets containing 1% alpha G-rutin with or without 1.5 or 3% DFAIII and FOS. Blood concentrations and urinary excretion of quercetin derivatives were largely and dose-dependently increased during the test period with feeding DFA III and FOS. The amounts of quercetin derivatives in the cecal contents and feces were also much higher in both saccharide groups than in the control group. The degradation rate of aglycone, estimated by differences between ingestion and sum of fecal and urinary excretion, were suppressed in the both saccharide groups. Cecal fermentation was dose-dependently modified by the oligosaccharides. It was concluded that suppression of degrading quercetin aglycone in the large intestine has a major role for increasing alpha G-rutin bioavailability by DFA III and FOS feedings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19178287     DOI: 10.1021/jf802390v

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

1.  Non-digestive stachyose enhances bioavailability of isoflavones for improving hyperlipidemia and hyperglycemia in mice fed with high fat diet.

Authors:  Yingmei Wu; Yalong Lu; Daoyuan Ren; Xuefeng Chen; Xingbin Yang
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

2.  Natural and glucosyl flavonoids inhibit poly(ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells.

Authors:  Junko Maeda; Erica J Roybal; Colleen A Brents; Mitsuru Uesaka; Yasushi Aizawa; Takamitsu A Kato
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.